Intranasal Lidocaine to Treat Pediatric Migraine in the Emergency Department
Clinical trial NCT03576820 · UNKNOWN
Trial details
- NCT number
- NCT03576820
- Sponsor
- New York City Health and Hospitals Corporation
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-15
- Primary completion
- 2022-12-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.